Cryoport Systems Global Supply Chain Center: Ready For Launch!

By Rob Jones, Vice President of Global BioServices, Cryoport Systems

The cell and gene therapy industry is growing and maturing rapidly, but the supporting infrastructure isn’t. As the number of therapy developers increases every month, the industry's manufacturing capacity remains limited, and the rising volume of materials in the supply chain is forcing companies to divert resources away from developing and manufacturing their therapies. Finding a reliable, experienced logistics partner, with suitable facilities to manage valuable materials – including the therapeutic materials and the raw materials that are used in the manufacturing process – is essential to match the unprecedented growth of cell and gene therapy developers around the world.

Driven by the industry's demand for optimized supply chain operations, Cryoport Systems recently launched its first two Global Supply Chain Centers, which will provide specialized storage and distribution solutions. These new solutions also provide a gateway to clinical trials and distribution in Europe, easing the regulatory burden as companies expand internationally. Discover the benefits of partnering with a trusted logistics partner who can match the capacity and solutions demanded by the growing cell and gene therapy industry and ensure the distribution of your company's life saving therapies to patients around the world.